On the morning of February 18, 2005, Biogen Idec of Cambridge, Massachusetts, learned that two patients in a clinical trial of its recently approved MS drug Tysabri (natalizumab) were suspected of ...

Debt funding also fell dramatically, from $11.6 billion in 2007 to about $3.2 billion last year, with Biogen Idec (Cambridge, MA, USA) raising a third of that through a $1 billion senior note deal ...

Biogen expects to record a $46 million expense as part of its second quarter earnings. The Cambridge, Mass., biotechnology company said Monday the expense is an in-process research and development, ...

The number of employees laid off and companies letting people go increased year over year during the first half of 2025. BioSpace recaps the five largest layoff rounds, including cuts at Bayer, BMS ...

New analyses from DEVOTE Part C further characterize the improvements in motor function in participants with SMA who ...

A new building of condominiums — including three affordable units — has been proposed for Brighton Center. Biotech's Future - ...

Assessing the distribution of a medication in the brain is critical for the treatment of a vast range of neurological ...

Detailed price information for Ionis Pharmaceuticals (IONS-Q) from The Globe and Mail including charting and trades.

New analyses from DEVOTE Part C further characterize the improvements in motor function in participants with SMA who transitioned to the investigational higher dose regimen of nusinersen from 12 mg SP ...

The problems cut across the industry as a whole. Many publicly traded biotech companies are now valued at less than the cash ...

Advice on the best ways to get around Cambridge, MA. How to get to and from the airport, plus how to use public transportation such as buses and taxis.

Kendall Square in Cambridge, Massachusetts. The underground substation project required the coordination of many city officials, local stakeholders and others. Editor's Note: Christopher Arnieri will ...